PHRF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.921600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.729200E-01
Normal-vs-Stage2
6.410400E-01
Normal-vs-Stage3
3.328400E-01
Normal-vs-Stage4
6.542800E-01
Stage1-vs-Stage2
9.304800E-01
Stage1-vs-Stage3
2.266000E-01
Stage1-vs-Stage4
8.455400E-01
Stage2-vs-Stage3
1.881850E-01
Stage2-vs-Stage4
9.395200E-01
Stage3-vs-Stage4
3.738000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.836600E-01
Normal-vs-AfricanAmerican
3.953800E-01
Normal-vs-Asian
9.355800E-01
Caucasian-vs-AfricanAmerican
6.014800E-01
Caucasian-vs-Asian
4.080400E-01
AfricanAmerican-vs-Asian
3.543000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.800800E-01
Normal-vs-Female
4.851400E-01
Male-vs-Female
4.004600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.892200E-01
Normal-vs-Age(41-60Yrs)
7.828200E-01
Normal-vs-Age(61-80Yrs)
5.060000E-01
Normal-vs-Age(81-100Yrs)
6.370400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.963400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.155200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.340800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.149030E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.163400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.827400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.016000E-01
Normal-vs-Daily Drinker
6.020400E-01
Normal-vs-Weekly Drinker
8.458600E-01
Normal-vs-Occasional Drinker
9.869400E-01
Normal-vs-Social Drinker
5.708000E-01
Non Drinker-vs-Daily Drinker
8.573000E-01
Non Drinker-vs-Weekly Drinker
7.209200E-01
Non Drinker-vs-Occasional Drinker
3.680800E-01
Non Drinker-vs-Social Drinker
7.729800E-01
Daily Drinker-vs-Weekly Drinker
5.947600E-01
Daily Drinker-vs-Occasional Drinker
2.457200E-01
Daily Drinker-vs-Social Drinker
8.891400E-01
Weekly Drinker-vs-Occasional Drinker
6.569200E-01
Weekly Drinker-vs-Social Drinker
5.484800E-01
Occasional Drinker-vs-Social Drinker
2.227400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.563600E-01
Normal-vs-Grade 2
8.865400E-01
Normal-vs-Grade 3
8.729200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.238400E-01
Grade 1-vs-Grade 3
2.234800E-01
Grade 1-vs-Grade 4
9.563600E-01
Grade 2-vs-Grade 3
7.674800E-01
Grade 2-vs-Grade 4
8.865400E-01
Grade 3-vs-Grade 4
8.729200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.986800E-01
Normal-vs-NonDiabetic
6.171800E-01
Diabetic-vs-NonDiabetic
7.988000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.206800E-01
Normal-vs-NoPancreatitis
5.489200E-01
Pancreatitis-vs-NoPancreatitis
3.182000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.418600E-01
Normal-vs-N1
5.786800E-01
N0-vs-N1
6.381000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.892600E-01
Normal-vs-TP53-NonMutant
4.393600E-01
TP53-Mutant-vs-TP53-NonMutant
7.053600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
